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Inhalation of 7.5% carbon dioxide increases anxiety and autonomic arousal and provides a novel
experimental model of anxiety with which to evaluate pharmacological and psychological treatments for
anxiety. To date several psychotropic drugs including benzodiazepines, SSRIs and SNRIs have been
evaluated using the 7.5% CO2 model; however, it has yet to be used to evaluate psychological in-
terventions. We compared the effects of two core psychological components of mindfulness-meditation
(open monitoring and focused attention) against general relaxation, on subjective, autonomic and
neuropsychological outcomes in the 7.5% CO2 experimental model.
32 healthy screened adults were randomized to complete 10 min of guided open monitoring, focused
attention or relaxation, immediately before inhaling 7.5% CO2 for 20 min. During CO2-challenge partic-
ipants completed an eye-tracking measure of attention control and selective attention. Measures of
subjective anxiety, blood pressure and heart rate were taken at baseline and immediately following
intervention and CO2-challenge.
OM and FA practice reduced subjective feelings of anxiety during 20-min inhalation of 7.5% CO2
compared to relaxation control. OM practice produced a strong anxiolytic effect, whereas the effect of FA
was more modest. Anxiolytic OM and FA effects occurred in the absence of group differences in auto-
nomic arousal and eye-movement measures of attention.
Our ﬁndings are consistent with neuropsychological models of mindfulness-meditation that propose
OM and FA activate prefrontal mechanisms that support emotion regulation during periods of anxiety
and physiological hyper-arousal. Our ﬁndings complement those from pharmacological treatment
studies, further supporting the use of CO2 challenge to evaluate future therapeutic interventions for
anxiety.
Crown Copyright © 2015 Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Inhalation of air enriched with 7.5% carbon dioxide (CO2) for
20 min increases self-report anxiety (e.g. worry, nervousness and
tension) and autonomic arousal (e.g. heart rate and blood pressure)
and provides a safe and reliable experimental model of anxiety in
healthy humans (Bailey et al., 2005). The subjective and autonomicof Southampton, Highﬁeld
92817.
insworth), m.j.garner@soton.
evier Ltd. This is an open access aeffects of 7.5% challenge are well characterised and are quantita-
tively and qualitatively less pronounced than the panic symptoms
elicited by the 35% CO2 model of panic (see Colasanti et al., 2008).
Recent studies suggest that in healthy individuals 7.5% CO2 inha-
lation can also induce a range of neuropsychological biases in
attention and emotion processing that characterize clinical anxiety
(review by Ainsworth and Garner, 2013). For example, 7.5% CO2
challenge impairs attention control and increases distractibility to
environmental threat cues in eye-tracking tasks (Garner et al.,
2011), and increases hyper-vigilance (Garner et al., 2012). Conse-
quently 7.5% CO2 challenge is considered a putative human exper-
imental model of subjective, autonomic and neuropsychologicalrticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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interventions, prior to phase-II/III clinical trials in patient pop-
ulations (Bailey et al., 2011a).
Initial validation studies have examined whether established,
licenced pharmacological treatments for anxiety can reduce CO2-
induced anxiety in healthy humans. Single doses of the benzodi-
azepines lorazepam (2 mg) and alprazolam (1 mg) reduce CO2-
induced subjective worry and anxiety (Bailey et al., 2007, 2009), as
does a 3-week course of the selective serotonin reuptake inhibitor
(SSRI) paroxetine (Bailey et al., 2007). A 7-day course of the
corticotropin-releasing factor antagonist R317573 also reduces
subjective response to CO2 (Bailey et al., 2011b), whilst pregabalin
and the serotonin-noradrenaline reuptake inhibitor venlafaxine
have more modest effects (Diaper et al., 2013, see Bailey et al.,
2011a, 2011b Table 3 for review). These ﬁndings suggest future
studies might use the CO2 model to examine the potential thera-
peutic efﬁcacy of other novel treatments for anxiety, including
psychological interventions.
Current treatment guidelines recommend cognitive-
behavioural therapies (CBT) as the ﬁrst-line psychological treat-
ment for mild to moderate anxiety. While meta-analyses highlight
the clinical effectiveness of CBT (Butler et al., 2006), access to CBT is
limited by long waiting lists and variation in local services (in part
due to cost of service delivery). Consequently, there is growing
interest in the use of affordable, low-intensity psychological in-
terventions for mild-moderate generalized anxiety that can more
easily be delivered in group-settings, and practiced at home with
remote/on-line support (Khoury et al., 2013). Of these,
mindfulness/meditation-based interventions offer initial promise
for a range of physical and neuropsychiatric conditions, including
stress and anxiety (see Chen et al., 2012 for a meta-analysis of
randomised controlled trials).
Mindfulness meditation techniques encourage deliberate,
objective/non-judgemental attention to internal and external
stimuli in the present moment (Williams and Kabat-Zinn, 2011).
Such techniques are often incorporated into 8-week Mindfulness-
based Stress Reduction (MBSR: Kabat-Zinn, 2003) interventions
(to reduce stress) and Mindfulness-based Cognitive Therapy
(MBCT: Teasdale et al., 2000), a version of MBSR developed for
patients with recurrent depression. MBSR can reduce physiological
responses to stress, including blood pressure (Carlson et al., 2007;
Palta et al., 2012) and salivary cortisol (Carlson et al., 2007;
Jensen et al., 2012). Briefer mindfulness interventions (3  1-
h sessions) can reduce heart-rate in healthy volunteers (Zeidan
et al., 2010). Mindfulness-meditation can also improve cognition
in healthy populations (see Chiesa et al., 2011, for a review),
including some cognitive processes that are perturbed in clinical
anxiety (e.g. deﬁcits in attention control, Ainsworth et al., 2013).
However, to optimise mindfulness-meditation interventions for
anxiety we need to isolate active component processes that
mediate anxiolytic response. Here we report ﬁndings from the ﬁrst
study to use a healthy human experimental model of anxiety to
evaluate and compare two core psychological components of
mindfulness meditation: focussed attention and open monitoring.
Neuropsychological models suggest focused attention and
open-monitoring are distinct components of mindful meditation
(Lutz et al., 2008; Manna et al., 2010; Holzel et al., 2011). Focused
attention (FA) involves restricting awareness to a volitionally cho-
sen object (e.g. localised sensation of breathing) and engaging in
‘self-monitoring’ for unwanted intrusive thoughts and distractions.
In contrast, open monitoring (OM) encourages active monitoring
and acceptance of internal and external sensation to promote a
receptive ﬁeld of non-judgemental awareness. By encouraging
awareness of internal emotional experiences, yet recognising them
as subjective and prone to personal bias, OM emphasizes affective/attitudinal facets, in contrast to FA, in which attentional skills are
more prominent.
In the present study healthy volunteers recruited from the
community were randomized to one of three intervention condi-
tions (FA, OM, relaxation control) immediately before completing
7.5% CO2-challenge and associated self-report measures of anxiety,
autonomic arousal and attention control (eye-tracking antisaccade
task, Garner et al., 2011). We predicted that OM and FA (compared
to relaxation control) would reduce self-report anxiety, autonomic
arousal and attention to threat during CO2-challenge. The existing
literature further suggests that OM and FA may target different
features of CO2-induced anxiety, with OM having a greater effect on
the subjective affective experience of CO2, whereas FA might ach-
ieve greater effects on attention control during CO2 challenge.
2. Method
2.1. Participants
10male and 22 female healthy young adultswith no prior formal
experience of mindfulness meditation were recruited through ad-
verts placed around the university campus and local community
(mean age¼ 21.7 years, SD¼ 3.2). A structured diagnostic interview
based on DSM-IV criteria (Mini International Neuropsychiatric
Interview eMINI; Sheehan et al., 1998) was used to screen eligible
participants. Exclusion criteria included prior experience with
mindfulness meditation, recent use of medication (during the past
eight weeks, except for topical treatments; occasional aspirin or
paracetamol; oral, injectable or skin patch contraception), preg-
nancy, history of asthma/respiratory illness, high blood pressure
(>140 systolic and/or 90 diastolic), cardiovascular disease, mi-
graines, current or lifetime history of psychiatric illness (including
lifetime history/family history of panic attacks), regular smoker
(more than 6 cigarettes/day), under- or over-weight (body mass
index less than 18 or greater than 28 kg/m2), current or past drug or
alcohol dependence and recent use of illicit drugs (during previous 8
weeks) or alcohol (veriﬁed bybreath test). Eligible participantswere
randomly assigned to one of three experimental groups in a single-
blind between-group design: focused attention meditation (FA:
N¼ 11), openmonitoringmeditation (OM:N¼ 11), and a relaxation
control (RC:N¼ 10). Participants received course credits or ﬁnancial
compensation for time spent (£20).
2.2. Methods and procedure
The study protocol was approved by the Ethics and Research
Governance ofﬁce at the University of Southampton and was in
accordance with the 2008 Declaration of Helsinki. All participants
provided informed consent prior to participation.
Participants attended a single test session and ﬁrst completed
established standardized self-report measures of trait anxiety
(STAI-trait: Spielberger et al., 1983), attention control (Attention
Control Scale, ACS: Derryberry and Reed, 2002) and dispositional
trait mindfulness (Mindful Attention Awareness Scale, MAAS:
Brown and Ryan, 2003).
The following primary outcome measures were taken at base-
line, immediately post-intervention and immediately after 7.5% CO2
challenge: heart rate (BPM), diastolic and systolic blood pressure
(Omron-M6 arm-cuff monitor, Medisave, UK), and visual analogue
ratings quantifying the extent to which participants felt ‘anxious’,
‘nervous’, and ‘worried’ (response scale ranged from ‘Not at all’ (0)
to ‘Extremely’ (100)). To allow comparison with previous studies
we administered the state version of the STAI (Spielberger et al.,
1983), and the Positive and Negative Affect Scale (PANAS; Watson
et al., 1988) at baseline, and immediately following 7.5% CO2
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intervention in order to limit the delay between completing the
intervention and commencing the CO2 challenge. All self-report
measures demonstrated good internal consistency (a's > 0.74).2.3. Psychological interventions
Each intervention lasted 10 min and was developed and recor-
ded by a consultant psychiatrist (DM) with clinical expertise in
delivering mindfulness-based interventions (since 2000) and
several thousand hours of personal mindfulness practice (since
1990). We have used these interventions in previous studies to
reveal effects of FA and OM on executive attention in healthy in-
dividuals (Ainsworth et al., 2013).
In the focused attention meditation, participants were asked to
“Find a place where the sensations of your breath are particularly
clear right now…at the tip of the nose, the back of the throat, the
chest or the abdomen”….“Make a decision to stay with this place
for the duration of this exercise rather thanmoving your awareness
from one place to another.”….“Turn your awareness towards this
place…allowing your awareness to settle on this point…allowing
the mind to become comfortable here”….“Maintain this focus, and
if themindwanders, gently return themind to this place.”…. “If you
ﬁnd your mind has wandered, lightly and ﬁrmly return your focus
to this place….”“Examining the sensation of the breath, andmaking
the focus of attention as ﬁne and as exact as possible e really
pinpoint this one point where the breath is observed.”
In contrast, in the open monitoring meditation participants
were asked to “Allow a sense of awareness of the breath and
physical sensations in the body generally to gradually expan-
d”….“Allowing your focus to include the sounds that you're hear-
ing, whatever the eyes see, and perhaps any smells, to come within
your ﬁeld of awareness.”…“Sitting here, with all of this, perhaps
allowing your emotional tone, how you are feeling right now, to
become part of this ﬁeld of awareness ewhatever sense of comfort
or discomfort, any emotions you feel right now, allowing that to
become part of your ﬁeld of awareness right now, noticing any
changes that may occur”. Control participants were asked to sit
quietly and relax. Participants subsequently completed post-
intervention measures followed by the CO2 challenge.Table 1
Group characteristics.
Trait characteristics
Focused Attention (FA) Open-monitoring (OM
STAI 33.5 (6.5) 35.0 (5.5)
MAAS 61.8 (6.6) 55.8 (6.9)
ACS 49.2 (8.2) 52.4 (5.7)
Mean autonomic scores across time (baseline vs. post-intervention vs. post-inhala
FA OM
Base Post-Int. Post-CO2 Base Post-Int. Post-CO
MAP 83.2 (6.7) 86.7 (12.2) 94.9 (9.5) 84.8 (9.4) 83.8 (9.1) 91.3 (12
HR 68.0 (9.5) 70.4 (10.3) 90.0 (18.0) 73.1 (16.1) 70.8 (17.9) 83.0 (28
Mean antisaccade error-rates and latencies by valence (negative vs. neutral)
FA OM
Neg. Neut. Neg. Ne
Error-rate .56 (.22) .61 (.22) .56 (.23) .59
Latency 183.1 (45.6) 182.4 (57.8) 168.4 (23.0) 190.8
Note: STAI ¼ Spielberger Trait Anxiety Inventory, MAAS ¼Mindfulness Attention Awaren
Rate.7.5% CO2 challenge: Participants inhaled air enriched with 7.5%
CO2 (21% O2, balance N2) for 20 min through an oral-nasal face
mask. Midway through the inhalation participants completed an
emotional version of the antisaccade eye-movement task in which
they were instructed to look towards (prosaccade) or look away
from (antisaccade) 8 negative and 8 neutral pictures selected from
the standardized International Affective Picture Set (see Garner
et al., 2011 for details). This task provides measures of attention
control (i.e. ability to inhibit eye-movements to pictures on anti-
saccade trials) and selective attention (i.e. speed and likelihood of
looking towards negative relative to neutral stimuli). Participants
completed 96 trials that were presented in a random order (24
trials per saccade-type  picture valence condition). Trials were
counter-balanced for stimulus location. The task was presented
using Inquisit 2 computer software. Consistent with Garner et al.
(2011) horizontal eye-movements were measured by electro-
oculography and sampled at 1000 Hz (MP150-ampliﬁer and Acq-
Knowledge 3.8.1 software, Biopac systems, Goleta, CA).
3. Results
3.1. Group characteristics
One-way ANOVAs conﬁrmed that groups did not differ in self-
report trait anxiety, attention control or mindfulness (see
Table 1). Scores were within the range typical of healthy non-
clinical samples (e.g. Garner et al., 2011). A Freeman-Halton
extension of Fisher's exact test conﬁrmed that groups did not
differ in gender, p ¼ .99, nor age, F(2,29) ¼ .90, p ¼ .42.
3.2. Effects of FA and OM on subjective anxiety
Visual analogue ratings were averaged to provide a composite
anxiety score and entered into a mixed design ANOVA with Group
(FA, OM, RC) as a between-subjects factor, and Time (baseline, post-
intervention, and post-CO2) as a within-subjects factor. Results
revealed a Group  Time interaction [F(4,58) ¼ 3.19, p ¼ .020,
h2P ¼ .18, 90% CI ¼ .02 to .28], see Fig 1. Follow-up analyses tested
whether intervention groups differed in anxiety i) immediately
after the intervention, and ii) following CO2 challenge, relative to) Relaxation control (RC) One-way ANOVA
33.4 (5.0) F(2,29) ¼ .28, p ¼ .76
57.9 (6.5) F(2,29) ¼ 2.26, p ¼ .12
50.7 (8.5) F(2,28) ¼ .46, p ¼ .63
tion)
RC
2 Base Post-Int. Post-CO2 Group  Time ANOVA
.5) 89.7 (8.2) 81.7 (10.3) 90.6 (10.8) F(4,58) ¼ 3.05, p ¼ .024, h2P ¼ .17
.4) 74.2 (11.7) 71.5 (11.4) 86.1 (10.8) F(4,58) ¼ 1.17, p ¼ .33
RC
ut. Neg. Neut. Group  emotion ANOVA
(.22) .42 (.17) .56 (.22) F(4,58) ¼ 1.17, p ¼ .33
(39.5) 178.7 (20.4) 183.4 (40.2) F(4,58) ¼ 1.29, p ¼ .29
ess Scale, ACS ¼ Attention Control Scale, MAP ¼Mean Arterial Pressure, HR ¼ Heart-
Fig. 1. Effects of FA, OM and RC on CO2 increased anxiety, F(4,58) ¼ 3.19, p ¼ .020 h2P ¼ .18, 90% CI ¼ .02 to .28.
B. Ainsworth et al. / Journal of Psychiatric Research 63 (2015) 117e122120baseline. Participants in each group reported lower levels of anxiety
following their intervention compared to baseline (p's  .05), but
the magnitude of this reduction did not differ across groups
[F(2,29) ¼ 0.69, p ¼ .51]. Consequently all three interventions pro-
duced comparable acute improvements in subjective mood. How-
ever in contrast, and as predicted, intervention groups differed in
their response to CO2-challenge [F(2,29) ¼ 4.42, p ¼ .021, h2P ¼ .23,
95% CIs ¼ .003 to .430]. The OM group experienced the smallest
increase in anxiety following CO2-challenge [M ¼ 9.35, t(10) ¼ 2.08,
p ¼ .06, 95% CI ¼ 19.38 to 0.68, dz ¼ 0.62], followed by the FA
group [M ¼ 18.16, t(10) ¼ 4.01, 95% CI ¼ 28.26 to 8.07, p ¼ .002,
dz ¼ 1.21], while the relaxation control group experienced the
largest increase in anxiety [M ¼ 31.20, t(9) ¼ 4.81, p ¼ .001, 95%
CI¼ 45.87 to 16.53, dz¼ 1.52]. Between-group comparisons provide
evidence that OM participants experienced less anxiety post-
inhalation than the relaxation control group [t(19) ¼ 2.28,
p¼ .034, ds¼ 0.99, 95% CI¼ 1.70 to 39.90], with some evidence that
FA had a more modest effect on CO2-induced anxiety compared to
the relaxation control group [t(19) ¼ 1.74, p ¼ .098, ds ¼ 0.76, 95%
CI ¼ 2.9 to 35.0], see Fig. 1.
Analyses of secondary measures taken at baseline and post-
inhalation revealed large Group  Time effects on STAI-state anx-
iety [F(2,29)¼ 5.13, p¼ .012, h2P ¼ .26, 90% CI¼ .04 to .42] but weaker
effects on positive and negative affect, see Table 1 [F(2,29) ¼ 3.67,
p ¼ .038, 90% CI ¼ .01 to .37, h2P ¼ .26; F(2,29) ¼ 2.75, p ¼ .081].3.3. Effects of FA and OM on heart rate and blood pressure
Measures of heart rate and mean arterial pressure
(2  DBP þ SBP)/3) were entered into separate mixed design
ANOVA with Group (FA, OM, RC) as a between-subjects factor, and
Time (baseline, post-intervention, and post-CO2) as a within-
subjects factor. CO2 challenge increased heart rate [F(2,29) ¼ 24.14,
p < .001, h2P ¼ 0.62, 90% CI ¼ .40 to .71] but this increase did not
differ across groups [F(4,58) ¼ 1.17, p ¼ .33]. CO2 challenge also
produced robust increases in blood pressure in each group
[F(2,29) ¼ 16.55, p < .001, h2P ¼ .53, 90% CI ¼ .28 to .64]. A
Group  Time interaction [F(4,58) ¼ 3.05, p ¼ .024, h2P ¼ .17, 90%
CI ¼ .01 to .27] suggests that this pattern differs across group,
however post-hoc tests suggest that this was driven by compara-
tively high BP in the RC group at baseline, rather than group dif-
ferences in the extent towhich CO2 increased blood pressure (mean
FA vs RC difference at baseline of 6.43 [t(19)¼ 1.97, p¼ .06]; no other
between-group differences at any time [ts < 1.26, ps > .22]).3.4. Effects of FA and OM on antisaccade performance during CO2
challenge
The direction and latency of eye-movements were scored
manually using AcqKnowledge software and blind to trial-type and
group membership, consistent with Garner et al., 2011. Anti-
saccade error rates and latencies were entered into separate
mixed-design ANOVA with group, and stimulus valence (negative
vs. neutral) as independent variables. There was evidence that
participants made more erroneous eye-movements towards
neutral relative to negative pictures [F(1,28) ¼ 10.21, p < .03,
h2P ¼ .27], however the omnibus analysis did not reveal clear effects
of group (nor interactions with group), Fs < 1.72, ps > .197.4. Discussion
Our ﬁndings are the ﬁrst to show that psychological techniques
employed in contemporary mindfulness-meditation interventions
can alleviate anxiety in an experimental healthy human experi-
mental model of anxiety. FA and OM practice reduced subjective
feelings of anxiety during 20-min inhalation of 7.5% CO2 compared
to relaxation control. OM practice produced a strong anxiolytic
effect, whereas the effect of FAwas more modest. Anxiolytic effects
of OM and FA occurred in the absence of group differences in
autonomic arousal e all three groups experienced large and com-
parable increases in heart rate and mean arterial blood pressure
following CO2-challenge. Contrary to predictions, neither OM nor
FA affected eye-trackingmeasures of attention control and selective
attention during CO2-challenge. Consequently OM, and to a lesser
extent FA, appear to have a selective effect on CO2-induced sub-
jective feelings of anxiety, but not autonomic or neuropsychological
consequences of CO2-challenge.
Consistent with mechanisms emphasized by recent neuropsy-
chological models of mindfulness meditation, our OM intervention
guided participants to regulate emotion through positive reap-
praisal, exposure, extinction and reconsolidation; that is, to
embrace whatever is present in the ﬁeld of awareness but approach
ongoing emotional reactions non-judgmentally and with accep-
tance of bodily and affective responses (see Holzel et al., 2011). In
contrast, FA practice encouraged non-appraisal (rather than re-
appraisal) through strict regulation of attention, and may have
achieved only modest anxiolytic effects through avoidance/sup-
pression of affective and physiological reactions. Recent evidence
suggests that individuals who report a dispositional tendency to
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less anxiety when actively suppressing the effects of a 90 s 15% CO2
inhalation challenge (Bullis et al., 2014). Together, these ﬁndings
suggest FA may promote suppression to reduce anxiety during
stress, whereas OM might activate a range of regulatory mecha-
nisms to achieve greater anxiolysis.
Might the anxiolytic effects of OM and FA reﬂect greater im-
mediate improvements in mood that sustain throughout the CO2-
challenge (i.e. residual carry-over effects)? Our results suggest not
e all three interventions produced comparable improvements in
mood from baseline to post-intervention, and there was no evi-
dence that baseline or post-intervention levels of anxiety moder-
ated the effects of OM and FA on CO2-induced anxiety. A more
parsimonious explanation is that OM, and to a lesser extent FA,
enabled participants to better regulate emotional experience dur-
ing CO2-challenge and autonomic hyper-arousal.
The effects of OM and FA in this model complement those of
established pharmacological treatments for anxiety. Benzodiaze-
pines and selective serotonin reuptake inhibitors both reduce 7.5%
CO2-induced subjective anxiety, but not autonomic arousal (Bailey
et al., 2007, 2009). Conversely drugs that target somatic
mechanisms, such as the non-selective adrenergic beta-blocker
propranolol do not reduce CO2-induced anxiety despite lowering
CO2-increased heart rate (Papadopoulos et al., 2010). Together
these ﬁndings suggest that psychological and pharmacological in-
terventions may un-couple established associations between sub-
jective and autonomic responses to CO2-challenge (Garner et al.,
2011, 2012; Pinkney et al., 2014), and may do so through similar
central neural mechanisms. For example, the subjective effects of
several classes of anxiolytic drugs are in-part mediated through
prefrontal down-regulation of sub-cortical mechanisms implicated
in anxious responding (e.g. amygdala and locus-coeruleus). Like-
wise, mindfulness training is associated with increased prefrontal
activity and prefrontal-amygdala connectivity, and corresponding
alleviation of symptoms in patients with generalized anxiety dis-
order (Holzel et al. 2011). Comparable effects of anti-panic medi-
cation and cognitive behaviour therapy on subjective response to
CO2-challenge in patients with panic disorder support a common
anxiolytic pathway (Gorman et al., 2004).
In the current study we extended the traditional 7.5% CO2 model
of anxiety to include an eye-tracking measure of attention control
and selective attention. Contrary to predictions, neither FA nor OM
improved antisaccade performance; rather, all three groups were
characterized by poor performance, with observed antisaccade
error rates comparable with those observed in previous CO2-chal-
lenge studies (Garner et al., 2011). Previous studies suggest that
acute interventions can increase attention control in unchallenged
healthy individuals (Dickenson et al., 2013), but that prolonged
practice can achieve larger improvements in cognitive control
(Ainsworth et al., 2013) and autonomic arousal (Jensen et al., 2012)
in unchallenged healthy populations, albeit in the absence of
changes in mood. Cross-sectional studies also suggest that in-
dividuals who report elevated trait/dispositional mindfulness
exhibit reduced anxiety during social stress paradigms, (Brown
et al., 2012), and that only individuals with high levels of trait
mindfulness exhibit a comprehensive subjective and physiological
anxiolytic response to short mindfulness interventions (e.g. 3
sessions  25 min; Creswell et al., 2007). Our study was not pow-
ered to examine the effect of trait mindfulness nor other trait
characteristics on response to FA/OM, and it is not surprising that
supplementary analyses did not identify trait predictors of
response to intervention, nor CO2-challenge. Accordingly, future
studies should identify predictors of subjective, autonomic and
neuropsychological response to brief and longer-term psychologi-
cal interventions in general, and particularly during periods ofanxiety (as modelled in the present study). To this end, the 7.5% CO2
model of anxiety is well placed to efﬁciently evaluate and help
optimize novel anxiolytic interventions for anxiety in healthy,
vulnerable/at-risk and clinical populations.
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